For research and educational purposes only. Not medical advice.
Epithalon Reference
Educational, not medical advice reference for Epithalon: Longevity; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Most evidence is preclinical. Human follow-up publications often involve epithalamin or older Russian geroprotector programs rather than contemporary independent epitalon trials.
Regulatory and posture
- Categories
- Longevity
- Aliases
- Epitalon, AEDG peptide, Epithalamin-related tetrapeptide
- Evidence posture
- translational - Human literature is older, indirect, and not the same as modern vial products.
- Regulatory status
- No FDA-approved Epithalon drug label. FDA lists Epitalon among bulk substances with safety-risk concerns.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: Epitalon mouse aging/cancer study
- PubMed: epithalamin elderly follow-up
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.